3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Esophageal Squamous Cell Carcinoma
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Lymphoma, Large B-Cell, Diffuse
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Waldenstrom Macroglobulinemia
1
Turcot syndrome
1
Testicular Neoplasms
1
Surgery
1
Stress, Psychological
1
Squamous Cell Carcinoma of External Auditory Canal
1
Solitary Fibrous Tumor, Pleural
1
Seminoma
1
Recurrence
1
Postoperative Complications
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Neoadjuvant Therapy
×
1 year
×
Clear all
No trials found.